Nuformix plc (FRA:1RT)

Nuformix Income Statement

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	-	-	-	-	0.05	0.2
Revenue Growth (YoY)	-	-	-	-	-74.43%	-63.45%
Cost of Revenue	-	-	-	-	0	0.06
Gross Profit	-	-	-	-	0.05	0.13
Selling, General & Admin	0.64	0.51	0.62	0.76	1.32	1.51
Other Operating Expenses	-	-	-	-	-	-0
Operating Expenses	0.64	0.51	0.62	0.76	1.32	1.51
Operating Income	-0.64	-0.51	-0.62	-0.76	-1.27	-1.37
Interest Expense	-	-	-	-	-	-0
EBT Excluding Unusual Items	-0.64	-0.51	-0.62	-0.76	-1.27	-1.38
Impairment of Goodwill	-3.14	-3.14	-	-	-	-
Pretax Income	-3.78	-3.65	-0.62	-0.76	-1.27	-1.38
Income Tax Expense	-0.01	-0.01	-0.05	-0	-0.16	-0.12
Net Income	-3.78	-3.64	-0.57	-0.76	-1.11	-1.25
Net Income to Common	-3.78	-3.64	-0.57	-0.76	-1.11	-1.25
Shares Outstanding (Basic)	1,096	787	719	708	598	581
Shares Outstanding (Diluted)	1,096	787	719	708	598	581
Shares Change (YoY)	49.81%	9.38%	1.58%	18.35%	3.07%	21.71%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.55	-0.33	-0.4	-0.43	-1.35	-0.85
Free Cash Flow Per Share	-0.00	-	-0.00	-0.00	-0.00	-0.00
Gross Margin	-	-	-	-	96.61%	68.14%
Operating Margin	-	-	-	-	-2540.54%	-701.96%
Profit Margin	-	-	-	-	-2217.99%	-641.01%
Free Cash Flow Margin	-	-	-	-	-2691.33%	-432.51%
EBITDA	-0.61	-0.48	-0.58	-0.72	-1.23	-1.28
D&A For EBITDA	0.04	0.03	0.04	0.04	0.04	0.09
EBIT	-0.64	-0.51	-0.62	-0.76	-1.27	-1.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.